Vδ1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by <b> <i>Trans</i> </b>-Retinoic Acid

Alessandro Poggi, Claudia Venturino, Silvia Catellani, +8

Cancer Research

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma

Anna Maria Raiola, Alida Dominietto, Riccardo Varaldo, +11

Bone Marrow Transplantation

Hematological MalignancyLymphoid NeoplasiaTransplantationHaploidentical BmtAdvanced Hodgkin ’ +7

FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias.

Giuseppe Visani, Patrizia Tosi, Pier Luigi Zinzani, +7

PubMed

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome

Maria Antonietta Aloe Spiriti, Roberto Latagliata, Pasquale Niscola, +22

Annals of Hematology

Hematological MalignancyBone Marrow FailureMedicineEpoetin AlfaHematology +5

Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study

Enrico Balleari, Edoardo Rossi, Marino Clavio, +7

Annals of Hematology

Hematological MalignancyBone Marrow FailureLaboratory HematologyHematologySingle-centre Study +5

High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia.

Marino Clavio, Paola Carrara, María Angélica Miglino, +12

PubMed

Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia

Livio Pagano, Alessandro Pulsoni, Maria Elena Tosti, +18

British Journal of Haematology

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents

Antonia Cagnetta, Debora Soncini, Stefania Orecchioni, +20

Haematologica

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Fabio Guolo, Luana Fianchi, Paola Minetto, +33

Blood Cancer Journal

Thalidomide in agnogenic and secondary myelofibrosis

Letizia Canepa, Filippo Ballerini, Riccardo Varaldo, +6

British Journal of Haematology